Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011854 (
type 1 diabetes
)
20,749
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A 4.7 kb cDNA of tyrosine phosphatase-like protein, phogrin, was isolated from a human islet cDNA library. Sequencing of the resulting clone identified a 3,045 residue open-reading frame encoding a 1,015 amino acid polypeptide with predicted molecular mass of 111,303 daltons. Phogrin's amino acid sequence has a single transmembrane region and one
putative tyrosine phosphatase
catalytic domain. Phogrin is 74% identical to the ICA512/IA-2 autoantigen of
type 1 diabetes
in the cytoplasmic domain, but only 29% in the luminal domain. It showed > 90% identity to rat phogrin and mouse IA-2 beta. Autoantibody radioassays utilizing full-length and the cytoplasmic domain of phogrin were compared. With positivity defined above the 99th percentile of 105 normal control subjects, 37 (48%) and 47 (61%) of sera from 77 new-onset patients with
type 1 diabetes
were positive for autoantibodies to full-length and the cytoplasmic domain of phogrin, respectively. The assay utilizing cytoplasmic human phogrin gave higher sensitivity with identical specificity to the assay utilizing the full-length molecule primarily due to lower "background" binding. Phogrin is an additional major autoantigen for
type 1 diabetes
and the isolation of the cDNA of this molecule from human islets will aid in studies of the pathogenesis of
type 1 diabetes
.
...
PMID:Molecular cloning and characterization of the human transmembrane protein tyrosine phosphatase homologue, phogrin, an autoantigen of type 1 diabetes. 887 34